Survival for adults and children with acute lymphoblastic leukaemia has risen substantially
in recent years because use of improved risk-directed treatments and supportive care has …

Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the
clonal expansion of hematopoietic lymphoid progenitors. With new target therapies, the …

Background The therapeutic progress for adults with acute lymphoblastic leukemia (ALL)
has been slow, with a 5-year survival of 30% to 45% in developed countries. Scarce …

Background Global death toll of Acute Leukemia (AL), as a heterogeneous group of
hematopoietic malignancies, is rather high, ie almost 74% of 300,000 new cases die every …

In this study, we aim to reveal the relationship between differentially expressed mRNAs and
genders in low grade glioma (LGG) patients. Based on the downloaded RNA-seq files of …

While many studies addressed the outcome of adult ALL in developed Western countries,
there is paucity of such prospective studies from developing Mediterranean ones. This is a …

Introduction: This study sought to investigate the immunophenotypic subtype profiles of 110
Chinese adult patients with acute lymphoblastic leukaemia (ALL) and its association to …

Background Acute lymphoblastic leukemia is a lymphoid malignancy, resulting from
autonomous proliferation of monoclonal abnormal stem cell. The aim of this study was to …

Aim: Chinese adults with relapsed/refractory Philadelphia chromosome-negative B-cell
precursor acute lymphoblastic leukemia (Ph-ALL) have poor outcomes. Patients & methods …

Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous group of lymphoid
neoplasms resulting from the proliferation of malignant lymphoid cells. The aim of this study …